Significance of Newly Approved IPX203 for... - Cure Parkinson's

Cure Parkinson's

26,583 members27,897 posts

Significance of Newly Approved IPX203 for Parkinson Disease

Farooqji profile image
20 Replies

Earlier this month, the FDA approved Amneal Pharmaceuticals’ investigational agent IPX203, an oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules, as a treatment for patients with Parkinson disease (PD). Marketed as Crexont, the therapy is an oral formulation CD/LD which includes immediate-release granules as well as extended-release pellets. In its announcement, Amneal noted it expects the oral treatment to be available to patients in the United States in September 2024.

neurologylive.com/view/sign...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
20 Replies
Buckholt profile image
Buckholt

So now it’s about the cost. If people can’t afford it or if in the UK the cost benefit analysis means it cannot be universally prescribed, then ………..

Smittybear7 profile image
Smittybear7

who would it be available to thanks for sharing

Grey_Area profile image
Grey_Area

I posted this info in another forum. The drug is also known as "Crexont".

What I can't find is what's so different about it compared to other controlled release L-Dopa products like Sinemet CR

Reading the info you'd be forgiven for thinking this was the first controlled release L-Dopa ever. In particular why have they benchmarked it against standard release rather than another CR product?

JPeezy profile image
JPeezy

sounds just like Rytary

rebtar profile image
rebtar

Very strange. I searched for Crexont vs Rytary, an article apeared, i could see the furst paragraph, but i couldnt get access. When i tried a second time, instead of the article, it said "page doesn't exist".

rebtar profile image
rebtar

pdexpertinstitute.com/exten...

Gioc profile image
Gioc in reply torebtar

In my opinion, these pellet medications always have a wide standard deviation (SD) that is not shown in the above graphs (figure 3; there should be vertical lines above each point). It would have been important to know this SD data in order to understand if the response to the medication is the same for everyone or subjective.

rebtar profile image
rebtar in reply toGioc

👍

Jmellano profile image
Jmellano

my neuro may consider switching me from Rytary to IPX203. He said the neuros need training on how to choose the right dosages and pricingt has to be provided. He thinks in my case, it may cut back on # times/ day IPX203 has to be taken. Currently, i take Rytary 4x/day

Jmellano profile image
Jmellano in reply toJmellano

It’s show time today.! Today is my first day on Crexont I am interested to see how effective

should be interesting to see how effective it is at nite for me.my uptimes are definitely are longer and it is great having to take pills only 3x per day.

You may have to have request that Crexont be added to the insurance company’s formulary.

Crexont is not cheap (what a surprise) my copay for a months supply was about$200, but I believe most of copay assistance companies will cover that.

the capsules are large and depending how my dysphagia is I may take with applesauce. I will update my experience going forward.

Farooqji profile image
Farooqji in reply toJmellano

Keep us updated

Jmellano profile image
Jmellano in reply toFarooqji

Will do, I think before I decide to stay on this instead of rytary, I will give it a week to settle in

Jmellano profile image
Jmellano in reply toJmellano

Still on the med, will stay on it for a week before I make an assessment, no issues so far

KOLACHKY profile image
KOLACHKY in reply toJmellano

Can you share the dosage transition amounts from Rytary to Crexont?

Jmellano profile image
Jmellano in reply toKOLACHKY

My Neuro had done it, not sure what he used for converting to Crexont, but I can tell you what daily amount I took of rytary and what he prescribed for Crexont

Rytary (5) 145s, (1) 99 taken in 5 doses

Crexont (6) 70/280 in 3 doses

I hope this helps. There are also websites that do some conversions

KOLACHKY profile image
KOLACHKY in reply toJmellano

Any updates on experience with Crexont?

Jmellano profile image
Jmellano in reply toKOLACHKY

hi, i WILL MOST LIKELY REMAIN ON CREXONT SINCE I ONLY HAVE TO TAKE IT 3X/DAY VS, 5X DAY WITH RYTARY

healthabc profile image
healthabc in reply toJmellano

Whats the Crexont update, if you don't mind sharing?

dkdc profile image
dkdc

ncbi.nlm.nih.gov/pmc/articl...

Rytary vs Crexont vs IR sinemet
Jmellano profile image
Jmellano

I just resumed taking it, 7am,1pm and 7 pm. Don’t think change of Crexont to rytary was reason I felt like crap, more likely it is ptogression.

Not what you're looking for?

You may also like...

Important Drug Approval for Parkinson Patients

Nuplazid, which the FDA designated as a breakthrough therapy and granted priority review, could...

Liquefy your L-dopa

The following method for liquefying L-dopa has been shown to have faster on time with less...
silvestrov profile image

Medium-Dose Lithium May Hit Parkinson Disease Targets...

I intentionally did not include the entire title of the article in the heading as I think it may be...

Mucuna pruriens in Parkinson’s

Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study R...

Mucuna Pruriens in Parkinson's disease, dosages and effects, A double-blind, randomized, controlled, crossover human study (2017)

Mucuna pruriens in Parkinson disease. A double-blind, randomized, controlled, crossover study...
Greenday profile image